Responding to the growing mandate for researchers to share their clinical data, WWARN is joining with partners to host a 3-day workshop in January sponsored by the British Council’s Newton Researcher Links Programme in order to develop the skills and network needed to produce high quality data capable of maximising the impact of initial findings.
Scoping available resources and tools used by investigators to set up and conduct malaria clinical trials in low and middle income countries within malaria endemic settings. Participate in the survey.
This video seminar describes research to develop a low-cost, field-based test to detect several slow-clearing ACT drug compounds from unprocessed fingerstick blood samples
Join us in Oxford on the 25th of April to mark World Malaria Day 2016 at a series of talks and a panel discussion. The speakers will present their latest projects and help us to understand the unique and interconnected findings of their research.
Malaria remains a major global health threat. In the last fifteen years there has been remarkable progress in reducing cases and deaths due to malaria.
Whilst our understanding of drug resistant Plasmodium falciparum is quite well understood, the extent and nature of resistance in Plasmodium vivax parasites is for the most part unknown.
New guidelines help researchers undertaking systematic reviews and IPD meta-analyses to report their findings in a full and transparent manner.
In this short video, Dr Christian Nsanzabana talks about why he is interested in antimalarial drug resistance and the ways in which WWARN are working to assess if resistance has developed outside of the Mekong region.
In this short video, Professor Ganguly talks about what a major health issue malaria was in India in the past.
In this video Prof Philippe Guérin discusses why it’s important to have timely, comprehensive and reliable information if we want to prevent or delay the spread of resistance.
In this video, Professor Theonest Mutabingwa discusses the two key challenges that face developing countries to progress their malaria research.
Anders Björkman is Professor of Infectious Disease at the Karolinska Institute. In this video, Anders talks about how the efficacy of antimalarials is a major obstacle in the path towards full malaria elimination.
Are you a research scientist working in Global Health? Or an institution looking for partners to run a clinical trial? Site Finder is for you.
CDC researcher discusses the benefits of attending the recent Ring-Stage Survival Assay training, an important tool for tracking antimalarial drug resistance, recently held in Cambodia by Institut Pasteur and WWARN.
The WWARN Gametocyte Carriage Study Group is assessing the risk factors associated with gametocyte carriage and clearance. Find out how you can join.
Our understanding of the extent and nature of resistance in P. vivax parasites is limited. WWARN’s new literature review summarises the global extent of reduced P. vivax susceptibility to the frontline antimalarial chloroquine.
WWARN has developed a library of standardised procedures that offers you guidance in the execution of various activities in the fields of clinical, in vitro, pharmacology and molecular analysis in regards antimalarial drug resistance.